0000000000347936

AUTHOR

Vincenzo Di Martino

showing 11 related works from this author

Effect of Sunlight Exposure on Anthocyanin and Non-Anthocyanin Phenolic Levels in Pomegranate Juices by High Resolution Mass Spectrometry Approach

2020

Quali-quantitative analyses of anthocyanins and non-anthocyanin phenolic compounds performed with the use of liquid chromatography coupled with high resolution mass spectrometry, were evaluated in juice of pomegranate fruits (&lsquo

0106 biological sciencesHealth (social science)Fruit weightPlant SciencephenolsHealth benefitslcsh:Chemical technology01 natural sciencesHealth Professions (miscellaneous)MicrobiologyArticlechemistry.chemical_compound0404 agricultural biotechnologyAntimicrobial effectUltra High Performance Liquid Chromatography -Orbitrap-Mass Spectrometrylcsh:TP1-1185Food scienceHPLC MSpomegranate juicessolar exposurepolyphenolsSunlightPunica granatumChemistryfungihydrolysable tanninsfood and beverages04 agricultural and veterinary sciences040401 food sciencecarbohydrates (lipids)PolyphenolAnthocyaninflavonoidsUltra High Performance Liquid Chromatography-Orbitrap-Mass Spectrometry010606 plant biology & botanyFood ScienceFoods
researchProduct

A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease

2022

Nonalcoholic fatty liver disease (NAFLD) is an emerging cause of liver-related events (LREs). Here, we have assessed the ability of a composite score based on clinical features, metabolic comorbidities, and genetic variants to predict LREs. A total of 546 consecutive patients with NAFLD were recruited and stratified according to the fibrosis-4 (FIB-4) index. LREs were defined as occurrence of hepatocellular carcinoma or hepatic decompensation. Cox regression multivariate analysis was used to identify baseline variables associated with LREs. The UK Biobank was used as the validation cohort, and severe liver disease (incidence of cirrhosis, decompensated liver disease, hepatocellular carcinom…

Liver CirrhosisCarcinoma HepatocellularHepatologyNon-alcoholic Fatty Liver DiseaseLiver NeoplasmsHumansNAFLD liver decompensation liver fibrosis cirrhosis liver-related events hepatocellular carcinoma
researchProduct

Unpublished Mediterranean records of marine alien and cryptogenic species

2020

Este artículo contiene 18 páginas, 4 figuras.

Invasions biològiques -- Mediterrània (Mar)geo-referenced records0206 medical engineeringNon-native speciesInvasive alien speciesLibrary sciencenon-native species non-indigenous distribution citizen science invasive alien species geo-referenced records Mediterranean Sea02 engineering and technologyAlienDistributionCitizen science01 natural sciencesRecords -- ManagementScience -- Mediterranean Region0103 physical sciencesAgency (sociology)citizen scienceCitizen sciencedistributionMediterranean Seamedia_common.cataloged_instancenon-indigenousZoología14. Life underwaterEuropean unionnon-indigenous speciesComputingMilieux_MISCELLANEOUSEcology Evolution Behavior and SystematicsGlobal environmental analysismedia_commonBiological invasions -- Mediterranean Seainvasive alien species010304 chemical physicsEcologySettore BIO/02 - Botanica SistematicaMarine reservenon-native speciesGeo-referenced records020601 biomedical engineeringEspècies introduïdes -- Mediterrània (Mar)Introduced organisms -- Mediterranean Sea13. Climate actionGeneral partnership[SDE]Environmental SciencesMarine protected areaCitizen science; Distribution; Geo-referenced records; Invasive alien species; Mediterranean Sea; Non-indigenous; Non-native speciesNon-indigenousScience -- Methodology -- Case studies
researchProduct

Impact of direct-acting antivirals (DAAs) on cardiovascular diseases in patients with chronic hepatitis C

2021

INTRODUCTION: In the last years the Hepatitis C virus (HCV) infection was a relevant public health problem due to the large number of affected people worldwide and the impact on hepatic and extrahepatic complications. The availability of direct-acting antivirals (DAAs) and the very high rate of sustained virological response (SVR) after treatment has radically changed the course of HCV chronic infection. EVIDENCE ACQUISITION: We searched PubMed for articles published between January 1, 1995, through December 31, 2020, in English language. EVIDENCE SYNTHESIS: Robust evidence showed a close link between HCV infection and development of cardiovascular disease (CVD), as result of the atherogeni…

medicine.medical_specialtyEndocrinology Diabetes and MetabolismHepatitis C virusMEDLINEHepacivirusDiseaseDIRECT ACTING ANTIVIRALSmedicine.disease_causeAntiviral AgentsVirusInternal medicineInternal MedicinemedicineHumansHepatitis chronic Cardiovascular diseases Antiviral agentsIn patientbusiness.industryPublic healthGastroenterologyvirus diseasesHepatitis C Chronicdigestive system diseasesChronic infectionCardiovascular DiseasesPersistent Infectionbusiness
researchProduct

Child-Pugh Class and Not Thrombocytopenia Impacts the Risk of Complications of Endoscopic Band Ligation in Patients with Cirrhosis and High Risk Vari…

2023

Background and Aims: Endoscopic band legation (EBL) is an effective method for the prophylaxis of acute variceal bleeding (AVB). This procedure may be associated with several complications, particularly bleeding. Our analysis aimed to evaluate the risk of complications due to EBL in a cohort of patients who underwent EBL for the prophylaxis of variceal bleeding and the eventual presence of risk predictors. Patients and Methods: We retrospectively analysed data from consecutive patients who underwent EBL in a primary prophylaxis regimen. For all patients, simultaneously with EBL, we recorded the Child–Pugh and MELD score, platelet count and US features of portal hypertension. Results: We col…

plateletesophageal band ligation (EBL)clinically significative portal hypertension (CSPH)variceal bleeding (ABV).Medicine (miscellaneous)MELD scorethrombocytopeniaChild–Pugh scorecirrhosi
researchProduct

PNPLA3 rs738409 C>G Variant Predicts Fibrosis Progression by Noninvasive Tools in Nonalcoholic Fatty Liver Disease

2020

Liver fibrosis is the main predictor of events in patients with nonalcoholic fatty liver disease (NAFLD),1 and its evolution is characterized by a nonlinear trend2,3 mostly affected by metabolic risk factors, severity of liver inflammation and steatosis, and weight loss.3 The rs738409 C>G common variant in PNPLA3 gene has been associated with severity of fibrosis and risk of liver-related events in NAFLD.4,5 Noninvasive tests as Fibrosis-4 (FIB-4) and liver stiffness measurement (LSM) are useful to rule-out advanced fibrosis and they could be reliable to predict fibrosis progression.2,6 We aimed to evaluate in patients with NAFLD whether PNPLA3 rs738409 C>G variant impacts on fibrosis…

Liver Cirrhosismedicine.medical_specialtyLiver fibrosisInflammationPolymorphism Single NucleotideGastroenterologyNon-alcoholic Fatty Liver DiseaseLiver stiffnessFibrosisInternal medicineNonalcoholic fatty liver diseasemedicineHumansGenetic Predisposition to DiseaseIn patientHepatologybusiness.industryMetabolic riskGastroenterologyNASHMembrane ProteinsLipasemedicine.diseaseFibrosisLiverSteatosismedicine.symptombusiness
researchProduct

GEMS, a GEnetic and Metabolic Staging predicting the outcome of non-alcoholic fatty liver disease

2021

Background and Aim: Non-alcoholic fatty liver disease(NAFLD) is an emergent cause of liver-related events(LRE). We have assessed the ability of a composite score based on clinical features, metabolic comorbidities and genetic background, to predict LRE. Methods: 546 consecutive patients with NAFLD were recruited and stratified according to FIB-4(low risk <1.3;intermedium-high risk ≥1.3). LRE were defined as occurrence of HCC or hepatic decompensation. Cox regression multivariate analysis was used to identify baseline variables associated with LRE. Results: Over a median follow-up of 73.8 months, 58 patients experienced LRE(only 1 in the cohort of patients with FIB-4 65 years(HR 17.96), plat…

medicine.medical_specialtyMultivariate analysisHepatologyProportional hazards modelbusiness.industryFatty liverGastroenterologyNon alcoholicDiseasemedicine.diseaseOutcome (game theory)GastroenterologyHelsinki declarationHepatocellular carcinomaDiabetes mellitusInternal medicineCohortMedicinebusinessTM6SF2Digestive and Liver Disease
researchProduct

Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment

2021

Abstract Aim This study investigated how material deprivation in Italy influences the stage of hepatocellular carcinoma (HCC) at diagnosis and the chance of cure. Methods 4114 patients from the Italian Liver Cancer database consecutively diagnosed with HCC between January 2008 and December 2018 were analysed about severe material deprivation (SMD) rate tertiles of the region of birth and region of managing hospitals, according to the European Statistics on Income and Living Conditions. The main outcomes were HCC diagnosis modalities (during or outside surveillance), treatment adoption and overall survival. Results In more deprived regions, HCC was more frequently diagnosed during surveillan…

Cancer Researchmedicine.medical_specialtySettore MED/12 - GastroenterologiaDeprivationbusiness.industryHepatocellular carcinomaPrognosiHazard ratioDeprivation; Hepatocellular carcinoma; Overall survival; Prognosis; Social determinants of healthmedicine.diseasePrognosisSocial determinants of healthOncologyInternal medicineHepatocellular carcinomamedicineOverall survivalOverall survivalSocial determinants of healthStage (cooking)businessLiver cancerSocioeconomic status
researchProduct

Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival

2022

Abstract Background An enhanced surveillance schedule has been proposed for cirrhotics with viral etiology, who are considered at extremely high-risk of hepatocellular carcinoma (HCC). Aims We compared the 3- and 6-months surveillance interval, evaluating cancer stage at diagnosis and patient survival. Methods Data of 777 HBV and HCV cirrhotic patients with HCC diagnosed under a 3-months (n = 109, 3MS group) or a 6-months (n = 668, 6MS group) surveillance were retrieved from the Italian Liver Cancer database. Survival in the 3MS group was considered as observed and adjusted for lead-time bias, and survival analysis was repeated after a propensity score matching. Results The 3-months surveil…

medicine.medical_specialtyCarcinoma HepatocellularSurvivalHepatocellular carcinomaCancer stageCancer stage; Hepatocellular carcinoma; Surveillance interval; SurvivalInternal medicinemedicineHumansPropensity ScoreSurveillance intervalSurvival analysisHigh risk patientsHepatologybusiness.industryCancer stageLiver NeoplasmsSettore MED/09 - MEDICINA INTERNAGastroenterologyPatient survivalmedicine.diseaseSurvival AnalysisHepatocellular carcinomaPropensity score matchingSurvival AnalysiLiver cancerbusinessMedian survivalHuman
researchProduct

RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE St…

2022

Noninvasive criteria to predict the progression of low-risk esophageal varices (EV) in patients with compensated hepatitis C virus (HCV) cirrhosis after sustained virological response (SVR) by direct-acting antivirals (DAAs) are lacking. Our aim was to assess the diagnostic performance of Rete Sicilia Selezione Terapia-HCV (RESIST-HCV) criteria for EV progression compared with elastography-based criteria (Baveno VI, Expanded Baveno VI, and Baveno VII-HCV criteria).All consecutive patients observed at 3 referral centers with compensated HCV cirrhosis with or without F1 EV who achieved sustained virological response by DAAs were classified at last esophagogastroduodenoscopy (EGDS) as RESIST-H…

Antiviral AgentMaleLiver CirrhosisHepatologyPlatelet CountLiver CirrhosiGastroenterologyHepacivirusHepatitis C ChronicEsophageal and Gastric VaricesAntiviral AgentsElasticity Imaging Techniques.Esophageal and Gastric VariceHumansElasticity Imaging TechniquesFemaleSerum AlbuminHumanAgedThe American journal of gastroenterology
researchProduct

Monofocal hepatocellular carcinoma: How much does size matter?

2020

Background &amp; Aims: According to the Barcelona Clinic Liver Cancer (BCLC) staging system, monofocal hepatocellular carcinoma (HCC) is classified as early (BCLC A) irrespective of its size, even though controversies still exist regarding staging and treatment of large tumours. We aimed at evaluating the appropriate staging and treatment for large (&gt;5 cm) monofocal (HCC). Methods: From the Italian Liver Cancer database, we selected 924 patients with small early monofocal HCC (2-5 cm; SEM-HCC), 163 patients with larger tumours (&gt;5 cm; LEM-HCC) and 1048 intermediate stage patients (BCLC B). Results: LEM-HCC patients had a worse overall survival (OS) than SEM-HCC (31.0 vs 49.0 months; P…

medicine.medical_specialtyMultivariate analysisCarcinoma HepatocellularIndependent predictorGastroenterologyResection03 medical and health sciences0302 clinical medicineInternal medicinemedicineOverall survivalHepatectomyHumansStaging systemNeoplasm StagingRetrospective StudiesSettore MED/12 - GastroenterologiaHepatologytreatmentbusiness.industrySettore MED/09 - MEDICINA INTERNALiver Neoplasmsbclc staging systemmonofocal hepatocellular carcinomamedicine.diseasedigestive system diseasesSurvival benefitItaly030220 oncology & carcinogenesisHepatocellular carcinomabclc staging system; liver resection; monofocal hepatocellular carcinoma; prognosis; treatmentliver resection030211 gastroenterology & hepatologyprognosisbusinessLiver cancerprognosi
researchProduct